Get started
Author

Erica Wilson

Observed names: E B Wilson, E. Wilson, Erica B Wilson, Erica B. Wilson, Erica B. Wilson, Wilson, Erica
Observed institutions: BC Cancer Agency, University of Leeds, King's College London, University of Cambridge, St James's University Hospital, University Medical Center Utrecht, Leeds Beckett University, Wellcome Trust, Medical Research Council
ORCID: 0000-0002-0441-728X
Observed ORCID: 0000-0002-0441-728X
OpenAlex ID: A5001990650
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
2018 · Adel Samson, Karen J. Scott, et al. · Science Translational Medicine · 374
Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity
2011 · Erica B. Wilson, Jehan J. El-Jawhari, et al. · PLoS ONE · 174
PDF
Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody
2003 · Peter A. Smethurst, Lotta Joutsi-Korhonen, et al. · Blood · 131
Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT
2014 · Tim D. Holmes, Erica B. Wilson, et al. · Proceedings of the National Academy of Sciences · 77
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
2019 · Helen J. Close, Lucy F. Stead, et al. · Clinical & Experimental Immunology · 72
PDF
Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma
2021 · Kelly J. McKelvey, Erica B. Wilson, et al. · Frontiers in Oncology · 53
PDF
Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cellsin vivo
2014 · Y M El-Sherbiny, T D Holmes, et al. · Clinical & Experimental Immunology · 37
GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
2023 · Shoaib Ajaib, Disha Lodha, et al. · Neuro-Oncology · 28
PDF
IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy
2024 · Georgette Tanner, Rhiannon Barrow, et al. · Genome biology · 22
PDF
Proteolytic Activation of the Cytotoxic Phenotype during Human NK Cell Development
2009 · Josephine L Meade, Erica B Wilson, et al. · The Journal of Immunology · 20
PDF
Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis
2016 · Milene Volpato, Sarah L Perry, et al. · Oncotarget · 15
PDF
Oncolytic virus treatment differentially affects the CD56dim and CD56bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity
2022 · Michelle Wantoch, Erica B. Wilson, et al. · Immunology · 14
PDF
Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing
2010 · Gina B. Scott, Paul A. Bowles, et al. · Biochemical Journal · 14
PDF
Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation
2003 · Minal T. Kotecha, Razi K. Afghan, et al. · Vaccine · 9
Cytokine receptor IL27RA is an NF-κB–responsive gene involved in CD38 upregulation in multiple myeloma
2023 · Rebecca J. Brownlie, Ruth Kennedy, et al. · Blood Advances · 8
PDF
Spatial profiling of longitudinal glioblastoma reveals consistent changes in cellular architecture, post-treatment
2025 · Shoaib Ajaib, Joshua Winter-Luke, et al. · Neuro-Oncology · 6
PDF
Expression of murine killer immunoglobulin-like receptor KIRL1 on CD1d-independent NK1.1+ T cells
2007 · Erica B. Wilson, Christine A. Parachoniak, et al. · Immunogenetics · 6
Modulation of GABA Neurotransmitter Signalling Impacts Glioblastoma Spheroid Growth and Response to Standard Treatment
2022 · Rhiannon Barrow, James A Poulter, et al. · Neuro-Oncology · 2
PDF
An MYC-Driven Vicious Circuit Is a Targetable Achilles’ Heel in Lymphoma
2023 · Erica B. Wilson, Ulf Klein · Blood Cancer Discovery · 1
PDF
IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy
2023 · Georgette Tanner, Rhiannon Barrow, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Targeting of Immune Cells by Human Adenoviruses: CD46 Receptor Density Influences Entry of Chimaeric Ad5F35 into Natural Killer Cells
2026 · Tyler Barr, Elif Aktar, et al. · International Journal of Molecular Sciences
Targeting of immune cells by human adenoviruses: CD46 receptor density influences entry of chimaeric Ad5F35 into natural killer cells
2026 · Tyler Barr, Elif Aktar, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Oncolytic virus treatment differentially affects the CD56 dim and CD56 bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity
2020 · Michelle Wantoch, Erica B. Wilson, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Intravenous delivery of oncolytic reovirus to brain tumours in patients to immunologically prime for sequential checkpoint blockade
2017 · Adel Samson, Karen J. Scott, et al. · White Rose Research Online (University of Leeds, The University of Sheffield, University of York)
P07.05 Intravenous delivery of oncolytic reovirus to brain tumours in patients to immunologically prime for sequential checkpoint blockade
2017 · A. Samson, K. Scott, et al. · Neuro-Oncology
PDF
Works count: 30
Citation count: 1,064
H-index: 13
I10-index: 13
Year
Topic
Type